Prevention of Stroke in Patients with Diabetes mellitus and the Metabolic Syndrome

By  

Cerebrovascular Diseases, Vol. 20, Iss. 1, 2005-11 ,pp. : 24-34

Karger

Access to resources Recommend Favorite

Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS

By Teede H.   Hutchison S.   Zoungas S.   Meyer C.  

Endocrine Journal, Vol. 30, Iss. 1, 2006-08 ,pp. : 45-53

Humana Press, Inc

Access to resources Recommend Favorite

Dual Peroxisome Proliferator-Activated Receptor-α/ Agonists: In the Treatment of Type 2 Diabetes Mellitus and the Metabolic Syndrome

By Pershadsingh Harrihar A.  

Treatments in Endocrinology, Vol. 5, Iss. 2, 2006-01 ,pp. : 89-99

Adis International

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor (PPAR) in Metabolic Syndrome and Type 2 Diabetes Mellitus

By  

Current Diabetes Reviews, Vol. 3, Iss. 1, 2007-02 ,pp. : 33-39

Bentham Science Publishers

Access to resources Recommend Favorite

Patients with Non-Insulin Depending Diabetes Mellitus and Metabolic Syndrome Are Suboptimal Treated in Swiss Primary Care

By Schäfer Hans Hendrik   de Villiers Jacob Daniel   Lotze Ulrich   Sivukhina Elena   Burnier Michel   Noll Georg   Theus Gian-Reto   Dieterle Thomas  

Clinical and Experimental Hypertension, Vol. 35, Iss. 7, 2013-11 ,pp. : 496-505

Informa Healthcare

Access to resources Recommend Favorite